🔎 Trials Near Me

홈 › 위암 › 텍사스

텍사스의 위암 임상 시험

위암 관련 연구 63개가 텍사스 내 여러 지역에서 참여자를 모집하고 있습니다.

텍사스의 도시

공식 연구 텍스트(영어)

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

  • NEXT Houston, Galveston
  • NEXT Oncology - PARENT, San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07360314

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  • The University of Texas Health Science Center at Tyler, Tyler
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT04198766

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

  • NEXT Oncology, Austin
  • UT Southwestern, Dallas
피험자 모집 중1상
19세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06586957

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

  • Texas Oncology - Amarillo Cancer Center, Amarillo
  • Texas Oncology-Austin Central, Austin
  • Texas Oncology, Beaumont
  • 외 4개
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07221149

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • The Don and Sybil Harrington Cancer Center, Amarillo
  • UT MD Anderson Cancer Center, Houston
  • Audie L Murphy VA Hospital, San Antonio
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05334069

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

  • Texas Oncology - DFW (Sammons CC), Dallas
  • Baylor College of Medicine, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07213791

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

  • Texas Oncology - DFW (Sammons CC), Dallas
  • MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07114601

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  • The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06760819

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

  • Texas Oncology - DFW, Dallas
  • MD Anderson Cancer Center, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06695845

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

  • MD Anderson Cancer Center, Houston
  • NEXT Dallas, Irving
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07578571

A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.

  • START San Antonio, LLC, San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07903415

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

  • Texas Oncology, Dallas
  • Oncology Consultants, Houston
  • Texas Oncology, Tyler
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT03526835

Lead-212 PSV359 Therapy for Patients With Solid Tumors

  • UT Southwestern University Hospital Radiology Clinic, Dallas
  • MD Anderson Cancer Center, Houston
피험자 모집 중1/2상
18세 ~ 90세 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT06710756

A Study of MGC026 in Participants With Advanced Solid Tumors

  • The University of Texas MD Anderson Cancer Center, Houston
  • University of Texas Health Science Center at Houston, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT06242470

[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

  • University of Texas Southwestern Medical Center, Dallas
피험자 모집 중1/2상
18세 ~ 80세 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT07432633

Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors

  • UT MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT06364410

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • The University of Texas MD Anderson Cancer Center, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06172478

Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic

  • NEXT Oncology Dallas, Irving
  • Texas Tech University Health Sciences Center, Lubbock
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07807345

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

  • The University of Texas MD Anderson Cancer Center, Houston
  • NEXT Oncology, San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT07705334

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

  • Research Site, Dallas
  • Research Site, Dallas
  • Research Site, Houston
  • 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 16. 업데이트됨 · NCT07431281

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid Tumors

  • Next Oncology Dallas /ID# 284346, Irving
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 16. 업데이트됨 · NCT07807956

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

  • MD Anderson Cancer Center, Houston
  • NEXT Oncology, San Antonio
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 15. 업데이트됨 · NCT06239194

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

  • Clinical Trial Site, San Antonio
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT07749586

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  • Start - Dfw, Fort Worth
  • Oncology Consultants, Houston
  • START - San Antonio, San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT06293898

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

  • US Oncology Investigational Products Center (IPC), Irving
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT07392892

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

  • The University of Texas MD Anderson Cancer Center, Houston
  • South Texas Accelerated Research Therapeutics (START), LLC, San Antonio
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT07070232

Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum

  • UT MD Anderson, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 8. 업데이트됨 · NCT07509008

A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer

  • Texas Oncology Arlington North, Arlington
  • Texas Oncology Bedford, Bedford
  • Texas Oncology Dallas Methodist, Dallas
  • 외 8개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 8. 업데이트됨 · NCT06038578

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

  • Research Site, Houston
  • Research Site, San Antonio
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 8. 업데이트됨 · NCT07115043

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

  • M D Anderson Cancer Center, Houston
피험자 모집 중2상
18세 ~ 79세 · 모든 성별 · 2026. 10. 6. 업데이트됨 · NCT03161522

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

  • Research Site, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT06219941

Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma

  • Baylor Scott & White Health, Dallas
  • MD Anderson Cancer Center, Houston
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07700979

IKS014 in Advanced Solid Tumors That Express HER2

  • START Dallas - Fort Worth, Fort Worth
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT05872295

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

  • Baylor, Scott and White Research Institute, Dallas
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06047379

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

  • Research Site, Houston
피험자 모집 중2상
18세 ~ 130세 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT05489211

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • MD Anderson, Houston
  • NEXT Dallas, Irving
  • NEXT Oncology San Antonio, San Antonio
  • 외 1개
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06128551

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

  • Texas Oncology (Balcones) - SCRI, Austin
  • MD Anderson Cancer Center, Houston
  • START South Texas Accelerated Research Therapeutics, San Antonio
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT05267626

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

  • Mary Crowley Cancer Research, Dallas
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06750185

A Phase 1/1b Study of IAM1363 in HER2 Cancers

  • NEXT Oncology - Austin, Austin
  • Mary Crowley Cancer Research, Dallas
  • MD Anderson Cancer Center - University of Texas, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06253871

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

  • NEXT Austin, Austin
  • NEXT San Antonio, San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 27. 업데이트됨 · NCT07227168

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.